RESUMEN
The bursa of Fabricius (BF) is the acknowledged central humoural immune organ unique to birds and plays a vital role in B lymphocyte development. In addition, the unique molecular immune features of bursal-derived biological peptides involved in B cell development are rarely reported. In this paper, a novel bursal heptapeptide (BP7) with the sequence GGCDGAA was isolated from the BF and was shown to enhance the monoclonal antibody production of a hybridoma. A mouse immunization experiment showed that mice immunized with an AIV antigen and BP7 produced strong antibody responses and cell-mediated immune responses. Additionally, BP7 stimulated increased mRNA levels of sIgM in immature mouse WEHI-231 B cells. Gene microarray results confirmed that BP7 regulated 2465 differentially expressed genes in BP7-treated WEHI-231 cells and induced 13 signalling pathways and various immune-related functional processes. Furthermore, we found that BP7 stimulated WEHI-231 cell autophagy and AMPK-ULK1 phosphorylation and regulated Bcl-2 protein expression. Finally, chicken immunization showed that BP7 enhanced the potential antibody and cytokine responses to the AIV antigen. These results suggested that BP7 might be an active biological factor that functions as a potential immunopotentiator, which provided some novel insights into the molecular mechanisms of the effects of bursal peptides on immune functions and B cell differentiation.
Asunto(s)
Proteínas Aviares/genética , Linfocitos B/inmunología , Bolsa de Fabricio/inmunología , Pollos/inmunología , Inmunidad Celular , Activación de Linfocitos/inmunología , Animales , Formación de Anticuerpos , Proteínas Aviares/inmunología , Femenino , Regulación de la Expresión Génica/inmunología , Inmunización , Inmunoglobulina M/inmunología , Ratones , Ratones Endogámicos BALB C , Análisis por Matrices de Proteínas , ARN Mensajero/metabolismoRESUMEN
The bursa of Fabricius (BF) is the key humoral immune organ unique to birds, and is critical for early B-lymphocyte proliferation and differentiation. However, the molecular basis and mechanisms through which the BF regulates B cell development are not fully understood. In this study, we isolated and identified a new bursal peptide (BP8, AGHTKKAP) by RP-HPLC and MALDI-TOF-MS. BP8 promoted colony-forming pre-B formation, bound B cell precursor, regulated B cell development in vitro as well as in vivo, upstream of the EBF-E2A-Pax5 regulatory complex and increased immunoglobulin secretion. These data revealed a bursal-derived multifunctional factor BP8 as a novel biomaterial which is essential for the development of the immune system. This study elucidates further the mechanisms involved in humoral immune system and has implications in treating human diseases.
Asunto(s)
Linfocitos B/citología , Bolsa de Fabricio/química , Péptidos/farmacología , Secuencia de Aminoácidos , Animales , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Bolsa de Fabricio/inmunología , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Pollos , Femenino , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Péptidos/inmunología , Péptidos/aislamiento & purificaciónRESUMEN
Bursa of Fabricius is the humoral immune system for B cell differentiation and antibody production. Bursopentine (BP5) is a novel immunomodulatory peptide and significantly stimulated an antigen-specific immune response in mice. BP5 was also found to protect LPS-activated murine peritoneal macrophages from oxidative stress. In this study, the effects of BP5 on B cell development were examined. The results suggested that BP5 markedly promoted B cell development by increasing CFU-pre B, and affected the redox homeostasis regulation of B cells. To study the molecular mechanism of effect of bursal-derived BP5, this research utilized 2D-E and MALDI-TOF/TOF to analyze the differentially expressed proteins of BP5-treated WEHI-231 cells. The results showed that BP5 affected the redox homeostasis regulation of WEHI-231 cells and induced alterations in the protein expression profiles related to the oxidoreduction coenzyme metabolic process, precursor metabolites and energy, proteolysis, RNA splicing and translation and cellular process, respectively. BP5 also induced glucose-6-phosphate dehydrogenase (G6PD) activity, an essential anti-oxidant cofactor. We found that the redox homeostasis regulation effect of BP5 was reduced in G6PD-deficient cells. These data suggested that BP5 affected the redox balance toward reducing conditions by promoting the expression of G6PD, which in turn regulated the glutathione redox cycle and other processes.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Linfocitos B/inmunología , Diferenciación Celular/efectos de los fármacos , Oligopéptidos/farmacología , Estrés Oxidativo/efectos de los fármacos , Animales , Linfocitos B/citología , Diferenciación Celular/genética , Diferenciación Celular/inmunología , Línea Celular , Glucosafosfato Deshidrogenasa/genética , Glucosafosfato Deshidrogenasa/inmunología , Homeostasis/efectos de los fármacos , Homeostasis/genética , Homeostasis/inmunología , Lipopolisacáridos/farmacología , Macrófagos Peritoneales/citología , Macrófagos Peritoneales/inmunología , Ratones , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/genética , Estrés Oxidativo/inmunologíaRESUMEN
The bursa of Fabricius, the acknowledged central humoral immune organ, plays a vital role in B lymphocyte differentiation. However, there are few reports of the molecular basis of the mechanism on immune induction and potential antitumor activity of bursal-derived peptides. In this paper, a novel bursal-derived pentapeptide-II (BPP-II, MTLTG) was isolated and exerted immunomodulatory functions on antibody responses in vitro. Gene microarray analyses demonstrated that BPP-II regulated expression of 2478 genes in a mouse-derived hybridoma cell line. Immune-related gene ontology functional procedures were employed for further functional analysis. Furthermore, the majority of BPP-II-regulated pathways were associated with immune responses and tumor processes. Moreover, BPP-II exhibited immunomodulatory effects on antigen-specific immune responses in vivo, including enhancement of avian influenza virus (H9N2 subtype)-specific antibody and cytokine production and modification of T cell immunophenotypes and lymphocyte proliferation. Finally, BPP-II triggered p53 expression and stabilization and selectively inhibited tumor cell proliferation. These data identified the multifunctional factor, BPP-II, as a novel biomaterial representing an important linking between the humoral central immune system and immune induction, including antitumor. Information generated in this study elucidates further the mechanisms involved in humoral immune system and represents the potential basis of effective immunotherapeutic strategies for treating human tumors and immune improvement.
Asunto(s)
Factores Inmunológicos/farmacología , Subtipo H9N2 del Virus de la Influenza A/metabolismo , Neoplasias/inmunología , Oligopéptidos/farmacología , Linfocitos T/inmunología , Animales , Anticuerpos Antivirales/inmunología , Bolsa de Fabricio/química , Bolsa de Fabricio/inmunología , Línea Celular Tumoral , Pollos/inmunología , Citocinas/inmunología , Femenino , Humanos , Factores Inmunológicos/química , Factores Inmunológicos/inmunología , Factores Inmunológicos/aislamiento & purificación , Ratones , Ratones Endogámicos BALB C , Neoplasias/tratamiento farmacológico , Neoplasias/patología , Oligopéptidos/química , Oligopéptidos/inmunología , Oligopéptidos/aislamiento & purificación , Proteína p53 Supresora de Tumor/inmunologíaRESUMEN
CoPoIFN-α is a recombinant non-naturally occurring porcine interferon-α (IFN-α). It was designed by scanning 17 porcine IFN-α nonallelic subtypes and assigning the most frequently occurring amino acid in each position. We used a porcine IFN-α (PoIFN-α) derived from domestic pig as a control. Both porcine IFN-α genes were introduced into yeast expression vector PpICZα-A and expressed in Pichia pastoris. The antiviral unit of these two IFN-αs were assayed in MDBK, PK-15 and MARC-145 cells against vesicular stomatitis virus (VSV), and their inhibitory abilities on pseudorabies virus (PRV) and porcine reproductive and respiratory syndrome virus (PRRSV) replication were also examined, respectively. We found the antiviral activity (units/mg) of CoPoIFN-α was 46.4, 63.6 and 53.5-fold higher than that of PoIFN-α for VSV inhibition in MDBK, PK-15 and MARC-145 cells, 4.8-fold higher for PRV inhibition in PK-15 cells, and 5-fold higher for PRRSV inhibition in MARC-145 cells. Our results also showed that the PRV and PRRSV-specific cytopathic effect (CPE) could be inhibited in the cells pretreated with CoPoIFN-α and PoIFN-α, and the virus titers in the cells pretreated with CoPoIFN-α were lower than those cells pretreated with PoIFN-α by 10-20-fold. The antiproliferative activity of CoPoIFN-α was significantly higher than that of PoIFN-α on a molar basis. The mRNA level of Mx1 and OAS1 genes in PK-15 cells induced by CoPoIFN-α were enhanced about 4.6-fold and 3.2-fold compared to that induced by PoIFN-α. Based on a homology model of CoPoIFN-α and IFNAR2, all of the different residues between native PoIFN-α and CoPoIFN-α were not involved in IFNAR1 binding site, and there is no direct interaction between these residues and IFNAR2, either. We speculate that the higher activity of CoPoIFN-α was likely due to the electrostatic potential introduced by residue Arg156 around the binding site or a structural perturbation caused by these different residues. This may enhance the overall binding affinity of CoPoIIFN-α and the receptors. Thus, CoPoIFN-α may have the potential to be used in therapy of porcine diseases.
Asunto(s)
Secuencia de Consenso , Interferón-alfa/biosíntesis , Interferón-alfa/genética , Proteínas Recombinantes/metabolismo , Secuencia de Aminoácidos , Animales , Antivirales/farmacología , Western Blotting , Bovinos , Línea Celular , Proliferación Celular/efectos de los fármacos , Dicroismo Circular , Efecto Citopatogénico Viral/efectos de los fármacos , Electroforesis en Gel de Poliacrilamida , Herpesvirus Suido 1/efectos de los fármacos , Interferón-alfa/química , Interferón-alfa/metabolismo , Modelos Moleculares , Datos de Secuencia Molecular , Pichia , Plásmidos/genética , Virus del Síndrome Respiratorio y Reproductivo Porcino/efectos de los fármacos , Estructura Secundaria de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Alineación de Secuencia , Homología Estructural de Proteína , Sus scrofa , Regulación hacia Arriba/efectos de los fármacos , Vesiculovirus/efectos de los fármacos , Replicación Viral/efectos de los fármacosRESUMEN
Epitope-based vaccination is a promising means to achieve protective immunity and to avoid immunopathology in Japanese encephalitis virus (JEV) infection. Several B-cell and T-cell epitopes have been mapped to the E protein of JEV, and they are responsible for the elicitation of the neutralizing antibodies and CTLs that impart protective immunity to the host. In the present study, we optimized a proposed multi-epitope peptide (MEP) using an epitope-based vaccine strategy, which combined six B-cell epitopes (amino acid residues 75-92, 149-163, 258-285, 356-362, 373-399 and 397-403) and two T-cell epitopes (amino acid residues 60-68 and 436-445) from the E protein of JEV. This recombinant protein was expressed in Escherichia coli, named rMEP, and its protective efficacy against JEV infection was assessed in BALB/c mice. The results showed that rMEP was highly immunogenic and could elicit high titer neutralizing antibodies and cell-mediated immune responses. It provided complete protection against lethal challenge with JEV in mice. Our findings indicate that the multi-epitope vaccine rMEP may be an attractive candidate vaccine for the prevention of JEV infection.
Asunto(s)
Virus de la Encefalitis Japonesa (Especie)/inmunología , Encefalitis Japonesa/prevención & control , Epítopos de Linfocito B/inmunología , Epítopos de Linfocito T/inmunología , Vacunas contra la Encefalitis Japonesa/inmunología , Péptidos/inmunología , Secuencia de Aminoácidos , Animales , Anticuerpos Antivirales/sangre , Clonación Molecular , Citocinas/biosíntesis , Epítopos de Linfocito B/genética , Epítopos de Linfocito B/uso terapéutico , Epítopos de Linfocito T/genética , Epítopos de Linfocito T/uso terapéutico , Inmunoglobulina G/sangre , Vacunas contra la Encefalitis Japonesa/uso terapéutico , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Células 3T3 NIH , Péptidos/genética , Péptidos/uso terapéutico , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/uso terapéutico , Linfocitos T Citotóxicos/inmunología , Células TH1/inmunología , Células Th2/inmunologíaRESUMEN
The bursa of Fabricius is an acknowledged central humoral immune organ unique to birds, which is vital to B cell differentiation and antibody production. However, the function and mechanism of the biological active peptide isolated from bursa on B cell development and autophagy were less reported. In this study, we isolated a new oligopeptide with nine amino acids Leu-Met-Thr-Phe-Arg-Asn-Glu-Gly-Thr from avian bursa following RP-HPLC, MODIL-TOP-MS, and MS/MS, which was named after BP9. The results of immunization experiments showed that mice injected with 0.01 and 0.05 mg/mL BP9 plus JEV vaccine generated the significant increased antibody levels, compared to those injected with JEV vaccine only. The microarray analysis on the molecular basis of BP9-treated immature B cell showed that vast genes were involved in various immune-related biological processes in BP9-treated WEHI-231 cells, among which the regulation of cytokine production and T cell activation were both major immune-related processes in WEHI-231 cells with BP9 treatment following network analysis. Also, the differentially regulated genes were found to be involved in four significantly enriched pathways in BP9-treated WEHI-231 cells. Finally, we proved that BP9 induced the autophagy formation, regulated the gene and protein expressions related to autophagy in immature B cell, and stimulated AMPK-ULK1 phosphorylation expression. These results suggested that BP9 might be a strong bursal-derived active peptide on antibody response, B cell differentiation, and autophagy in immature B cells, which provided the linking among humoral immunity, B cell differentiation, and autophagy and offered the important reference for the effective immunotherapeutic strategies and immune improvement.
Asunto(s)
Anticuerpos Antivirales/sangre , Autofagia , Linfocitos B/inmunología , Bolsa de Fabricio/química , Inmunidad Humoral , Oligopéptidos/inmunología , Animales , Bolsa de Fabricio/inmunología , Diferenciación Celular/inmunología , Línea Celular , Pollos , Femenino , Vacunas contra la Encefalitis Japonesa/inmunología , Ratones , Ratones Endogámicos BALB C , Análisis de Matrices TisularesRESUMEN
[This corrects the article DOI: 10.1038/s41421-018-0028-z.].
RESUMEN
Adjuvants play an important role in the formulation of effective and appropriate vaccines. A series of synthetic bursin and bursin-like peptides was heterologously expressed in Escherichia coli. The use of bursin as an adjuvant enhanced the specific immune responses of mice immunized with a recombinant Japanese encephalitis virus E-binding domain (JEV E-BD) fusion protein. The effect was determined in the form of protective anti-JEV E titers, antibodies (IgG1 and IgG2a), spleen cell lymphocyte proliferation, the levels of interferon-gamma and interleukin-4 cytokines, and the T-lymphocyte sub-type composition. The IgG2a titer and interferon-gamma level suggested that the E-BD protein potentiates the Th1 immune response. These responses were changed when the immunogen was combined with one of the synthetic peptides as adjuvant. JEV-neutralization assay results show that the presence of bursin significantly enhance the JEV-neutralizing titer. We conclude that bursin as an adjuvant is a potent enhancer of immune response in mice immunized with the JEV subunit vaccine, and represents a promising adjuvant for vaccination.
Asunto(s)
Vacunas contra la Encefalitis Japonesa/inmunología , Oligopéptidos/inmunología , Adyuvantes Inmunológicos , Animales , Anticuerpos Antivirales/sangre , Proliferación Celular , Femenino , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Vacunas contra la Encefalitis Japonesa/administración & dosificación , Linfocitos/fisiología , Ratones , Pruebas de Neutralización , Subunidades de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/inmunología , Bazo/citologíaRESUMEN
BACKGROUND: The bursa of Fabricius (BF) is an acknowledged central immune organ, and is important to B cell differentiation. Bursal hexapeptide (BHP) is the recently reported bursalderived peptide, while its inducing function on immune response is uncertain. OBJECTIVES: The main objective of this study was to analyze the immune responses to JEV vaccine in mice induced by BHP plus JEV vaccine, and to detect the signal and biological functions of BHP on immature B cells. METHODS: Mice were immunized with Japanese encephalitis virus (JEV) vaccine and BHP from 0.01 mg/mL to 0.25 mg/mL to detect antibody response and cellular immune response, respectively. The production of IgG, IgG1 and IgG2a specific to JEV in serum from immunized mice were measured by ELISA, and T cell subpopulation from immunized mice were detected with using fluorochrome conjugated mAbs of the corresponding PE-Cys/FITC/PE by flow cytometry. Spleen cells from all immunized mice were harvested after one week of second immunization for lymphocyte proliferation assay. Mouse immature B cell WEHI-231 cell was treated with 0.01µg/mL BHP for 4h, and analyzed the involved biological function and pathway of differentially expressed genes with gene microarray. RESULTS: BHP co-immunization with JEV vaccine generated significant increased antibody levels, neutralizing antibody titers and spleen lymphocyte viability, compared to that of vaccine control. The subpopulations of T cells in spleen lymphocytes were significantly modified in the mice coimmunized with JEV vaccine and BHP. The analysis results of gene expression profiles of WEHI- 231 mouse immature B cells with BHP treatment showed that the regulated genes with BHP treatment were involved various immune related biological functions, including proliferation and activation of lymphocyte and T cell, T cell mediated immunity and regulation of adaptive immune response. Furthermore, BHP stimulated three significant enriched pathways, including amphetamine addiction, long-term potentiation, and RIG-I-like receptor signaling pathway. CONCLUSION: Our results indicated BHP induced significant humoral and cellular immunity to JEV vaccine, and regulated various biological processes and signalling related to immune activation in immature B cells. These results proposed the immunomodulatory function and mechanism of BHP on immune induction, which provided the novel insight on the candidate reagent for immune improvement.
Asunto(s)
Formación de Anticuerpos/efectos de los fármacos , Virus de la Encefalitis Japonesa (Especie)/inmunología , Oligopéptidos/farmacología , Células Precursoras de Linfocitos B/efectos de los fármacos , Vacunas Virales/inmunología , Animales , Bolsa de Fabricio/metabolismo , Diferenciación Celular , Supervivencia Celular , Femenino , Inmunidad Celular , Inmunidad Humoral , Inmunoglobulina G/sangre , Ratones Endogámicos BALB C , Oligopéptidos/síntesis química , Oligopéptidos/inmunología , Células Precursoras de Linfocitos B/inmunología , Transducción de Señal , VacunaciónRESUMEN
According to the partiality codon of Pichia pastoris, hybrid antimicrobial peptide CecA-mag gene was synthesized and cloned into pPICZa-A to construct the recombinant expression vector pPICZa-A-CA. The SacI-linearized plasmid pPICZalpha-A-CA was transformed into P. pastoris SMD1168 by electroporation. Under the control of the promoter AOX'(alcoholoxidase') , an approximately 1.9kDa cecA-mag protein was expressed. Antibacterial assays demonstrated that cecA-mag had broad spectrum of antimicrobial property against Gram-positive as well as Gram-negative bacteria especially showed potent antibacterial activity against ampicillin resistant bacteria, such as pathogenic E. coli. In addition, the hybrid antibacterial peptide showed an extreme heat stable and acid stable characteristic. These results suggest that the P. pastoris expression system can be used to produce large quantities of fully functional cecA-mag for both research and industrial purpose. Based on these characteristics, the recombinant antibacterial peptide cecA-mag displays application foreground in the field of prevention of disease, and can be used as additives of animal feedstuff and so on.
Asunto(s)
Péptidos Catiónicos Antimicrobianos/genética , Magaininas/genética , Pichia/genética , Proteínas Recombinantes de Fusión/biosíntesis , Péptidos Catiónicos Antimicrobianos/farmacología , Bacterias/efectos de los fármacos , Concentración de Iones de Hidrógeno , Magaininas/farmacología , Proteínas Recombinantes de Fusión/farmacología , TemperaturaRESUMEN
To obtain recombinant chicken interferon gamma (ChIFN-gamma) with natural antivirus bioactivity in yeast Pichia pastoris eukaryotic expression system, the cDNA of chicken interferon gamma mature protein was synthesized by reverse transcription-polymerase chain reaction (RT-PCR)from the total mRNA of the lymphocyte from chicken blood, which stimulated with Con A for 4 to approximately 10 hours. The 493 bp nucleotide sequence of chicken interferon gamma mature protein was cloned into expression vector pPICZa-A, which had been cleaved between EcoR I and Xba I . After linearized by BstX I, the recombinant vector was transferred into yeast Pichia pastoris, strain X33. The recombinant strain was isolated and identified by polymerase chain reaction. After induced by methanol, the recombinant protein was examined by SDS-PAGE. The result of SDS-PAGE analysis in the concentrated fermentation supernatant showed that the molecular weight of the recombinant protein was approximate 16kDa, two recombinants were conformed to secrete chicken interferon gamma(16kDa). The classical experiment of detection for interferon activity (cell pathological Effect Inhibition Assay)and the preliminary result of therapy proved that the recombinant protein is of good antivirus activity. So far chicken interferon gamma had been expressed highly in E. coli, but it tend to form biologically inactive inclusion bodied combined with difficulties in refolding, so the recombinant chicken gamma interferon with natural antivirus bioactivity produced in yeast expression system is the best way, the recombinant interferon gamma have great practical value and application foreground.
Asunto(s)
Antivirales/farmacología , Interferón gamma/biosíntesis , Enfermedad de Newcastle/tratamiento farmacológico , Animales , Pollos , Expresión Génica , Interferón gamma/genética , Interferón gamma/aislamiento & purificación , Interferón gamma/farmacología , Pichia/metabolismo , Proteínas Recombinantes , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
In order to develop recombinant porcine interferon beta with high bioactivity, the rare codes that encoded 3th, 7th and 164th amino acids of porcine interferon beta mature protein were mutant into bias codes of Pichia pastoris and then the modified gene was introduced to yeast secreted expression vector pPICZ alphaA which resulted in pPICZalphaA-PIB. The SacI linearized plasmid pPICZalphaA-PIB was transformed into Pichia pastoris X-33 by electroporation. The transformants were identified by PCR using PoIFN-beta and AOX1 specific primers. The expression of PoIFN-beta was induced with methanol. Several positive clones were obtained and the one namely B1 produced the highest level of PoIFN-beta. The B1 was further fermented in shake-flask in larger volume. The concentration of the secreted PoIFN-beta was about 60 microg/mL and its antiviral activity is about 2.5 x 10(5) U/mL, so the specific activity of porcine interferon beta produced by the Pichia pastoris is approximately 4.17 x 10(6) U/mg. The expressed supernatant was concentrated and identified by SDS-PAGE and Western blot. There are two major proteins with respective molecular mass of approximately 25 kDa and 28 kDa in the supernatant. The results of Western blot indicated that the two proteins were positively reacted and manifested well PoIFN-beta antigenicity. In contrast with the deduced theoretical molecular mass value of PoIFN-beta, the expressed two major proteins were larger which maybe due to the difference of glycosylation. The antiviral effect of recombinant porcine interferon beta (rPoIFN-beta) on Pseudorabies virus (PrV) was studied in the present experiment. The result indicated that rPoIFN-beta could effectively inhibit the replication of PrV in MDBK cells, especially during the early phage of the virus replication.
Asunto(s)
Herpesvirus Suido 1/efectos de los fármacos , Herpesvirus Suido 1/fisiología , Interferón beta/genética , Interferón beta/farmacología , Pichia/metabolismo , Porcinos , Replicación Viral/efectos de los fármacos , Animales , Línea Celular , Clonación Molecular , Expresión Génica , Ingeniería Genética , Interferón beta/biosíntesis , Interferón beta/aislamiento & purificación , Pichia/genética , Análisis de Secuencia de ADNRESUMEN
According to the antigenic analysis of equine arteritis virus (EAV) GL protein, one pair of primers were designed, with which the gene fragment coding the high antigenic domain of EAV GL protein was amplified from the EAV genome. The cloned gene was digested with BamH I and Xho I and then inserted into pET-32a and resulted pET-GL1. The pET-GL1 was transformed into the host cell BL21(DE3) and the expression was optimized including cultivation temperature and concentration of IPTG. The aim protein was highly expressed and the obtained recombinant protein manifested well reactiongenicity as was confirmed by Western blot. The recombinant GL1 protein was purified by the means of His * Bind resin protein purification procedure. Then an indirect ELISA was established to detect antibody against EAV with the purified GL1 protein as the coating antigen. The result showed that the optimal concentration of coated antigen was 9.65 microg/mL and the optimal dilution of serum was 1:80. The positive criterion of this ELISA assay is OD (the tested serum) > 0.4 and OD (the tested serum) /OD (the negative serum) > 2.0. The iGL-ELISA was evaluated versus micro-virus neutralization test. The ELISA was performed on 900 sera from which were preserved by this lab during horse entry/exit inspection, the agreement (94.1%) of these test were considered suitable for individual serological detection. In another test which 180 sera samples were detected by iGL-ELISA and INGEZIM ELISA kit respectively. The agreement ratio between the two methods is 95.6%.
Asunto(s)
Antígenos Virales/genética , Equartevirus/inmunología , Células Procariotas/metabolismo , Proteínas Virales/biosíntesis , Proteínas Virales/química , Anticuerpos/análisis , Anticuerpos/inmunología , Western Blotting , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Expresión Génica , Vectores Genéticos/genética , Vectores Genéticos/metabolismo , Reacción en Cadena de la Polimerasa , Estructura Terciaria de Proteína , Sensibilidad y Especificidad , Proteínas Virales/genética , Proteínas Virales/inmunologíaRESUMEN
Japanese encephalitis (JE) is a mosquito borne viral disease, caused by Japanese encephalitis virus (JEV) infection producing severe neuroinflammation in the central nervous system (CNS) with the associated disruption of the blood brain barrier. MicroRNAs (miRNAs) are a family of 21-24 nt small non-coding RNAs that play important post-transcriptional regulatory roles in gene expression and have critical roles in virus pathogenesis. We examined the potential roles of miRNAs in JEV-infected suckling mice brains and found that JEV infection changed miRNA expression profiles when the suckling mice began showing nervous symptoms. A total of 1062 known and 71 novel miRNAs were detected in JEV-infected group, accompanied with 1088 known and 75 novel miRNAs in mock controls. Among these miRNAs, one novel and 25 known miRNAs were significantly differentially expressed, including 18 up-regulated and 8 down-regulated miRNAs which were further confirmed by real-time PCR. Gene ontology (GO) and signaling pathway analysis of the predicted target mRNAs of the modulated miRNAs showed that they are correlated with the regulation of apoptosis, neuron differentiation, antiviral immunity and infiltration of mouse brain, and the validated targets of 12 differentially expressed miRNAs were enriched for the regulation of cell programmed death, proliferation, transcription, muscle organ development, erythrocyte differentiation, gene expression, plasma membrane and protein domain specific binding. KEGG analysis further reveals that the validated target genes were involved in the Pathways in cancer, Neurotrophin signaling pathway, Toll like receptor signaling pathway, Endometrial cancer and Jak-STAT signaling pathway. We constructed the interaction networks of miRNAs and their target genes according to GO terms and KEGG pathways and the expression levels of several target genes were examined. Our data provides a valuable basis for further studies on the regulatory roles of miRNAs in JE pathogenesis.
Asunto(s)
Encéfalo/metabolismo , Encéfalo/virología , Virus de la Encefalitis Japonesa (Especie) , Encefalitis Japonesa/genética , Encefalitis Japonesa/virología , Perfilación de la Expresión Génica , MicroARNs/genética , Transcriptoma , Animales , Encéfalo/patología , Línea Celular , Biología Computacional/métodos , Modelos Animales de Enfermedad , Encefalitis Japonesa/patología , Regulación de la Expresión Génica , Redes Reguladoras de Genes , Secuenciación de Nucleótidos de Alto Rendimiento , Ratones , Interferencia de ARN , ARN Mensajero/genética , Análisis de Secuencia de ARNRESUMEN
According to the partiality codon of Pichia pastoris, hybrid antimicrobial peptide CecA-mil gene was reconstructed, synthesized and cloned into pPICZalpha-A to construct the recombinant expression vector pPICZa-A-CM. The pPICZalpha-A-CM was transformed into yeast host strain X-33. Under the control of the promoter AOX1 (alcohol oxidase 1), a approximately 1.9 kD cecA-mil protein was expressed with the high level of 245 microg/mL after optimized the requirements for the flask-shaking culture fermentation of the Pichia pastoris rX-33/pPICZalpha-A-CM. The hybrid antibacterial peptide had a broad spectrum antibacterial activity on both gram-positive and gram-negative bacteria, especially showed potent antibacterial activity against ampicillin-resistant and kanamycin- resistant bacteria, such as Staphylococcus aureus (cowan I) and pathogenic E. coli (O1) from chicken. In addition, the hybrid antibacterial peptide showed an extreme heat-stable and acid-stable characteristic. Based on these characteristics, the recombinant antibacterial peptide CecA-mil display application foreground in the field of antisepsis of food, prevention of disease, additives of animal feedstuff and so on.
Asunto(s)
Antiinfecciosos/farmacología , Péptidos Catiónicos Antimicrobianos/biosíntesis , Péptidos Catiónicos Antimicrobianos/genética , Bacterias/efectos de los fármacos , Pichia/genética , Antiinfecciosos/química , Péptidos Catiónicos Antimicrobianos/química , Péptidos Catiónicos Antimicrobianos/farmacología , Fermentación , Pruebas de Sensibilidad Microbiana , Transformación GenéticaRESUMEN
The site-directed mutagenesis of HA gene was made by using PCR, and mismatches were introduced into primers. Mutagenesis was performed in a three-step PCR. The amplified fragments from the second PCR which contained the mutation site were cloned into the pcDNA3 vector, named pHAm. The sequencing analysis showed that the mutation site was correct. The amino acid sequence at the cleavage site of the HA protein was from RKKR decrease GLF to RSSR decrease GLF. The recombinant plasmid pHAm was transiently transfected into 293T cells by the calcium phosphate precipitation method. Indirect immunofluorescent assay (IFA), confirmed expression of the HA protein on the cell membrane, the mutant HA gene was a promising candidate for further studies.
Asunto(s)
Glicoproteínas Hemaglutininas del Virus de la Influenza/genética , Subtipo H5N1 del Virus de la Influenza A/genética , Reacción en Cadena de la Polimerasa/métodos , Secuencia de Aminoácidos , Línea Celular , Técnica del Anticuerpo Fluorescente Indirecta , Glicoproteínas Hemaglutininas del Virus de la Influenza/química , Glicoproteínas Hemaglutininas del Virus de la Influenza/fisiología , Humanos , Mutagénesis Sitio-Dirigida , TransfecciónRESUMEN
The bursa of Fabricius (BF) is the acknowledged central humoral immune organ in birds. Bursal septpeptide II (BSP-II) is an immunomodulatory bioactive peptide isolated from BF. To understand the effects of BSP-II on immune induction, gene expression profiles of hybridoma cells treated with BSP-II were evaluated. Pathway analysis showed that regulated genes were involved in cytokine-cytokine receptor interactions, T cell receptor signaling pathway, and pathway in cancer. It was observed that BSP-II reduced tumor cells proliferation and stimulated p53 expression. These results indicate potential mechanisms underlying the effects of the humoral immune system on immune induction, including antitumor activities. Our study has provided a novel insight into immunotherapeutic strategies for treating human tumors.
Asunto(s)
Antineoplásicos/farmacología , Proteínas Aviares/farmacología , Pollos/inmunología , Factores Inmunológicos/farmacología , Transducción de Señal/efectos de los fármacos , Transcriptoma , Animales , Bolsa de Fabricio/inmunología , Proliferación Celular/efectos de los fármacos , Hibridomas/efectos de los fármacos , Análisis de Secuencia por Matrices de Oligonucleótidos/veterinariaRESUMEN
A study was initiated with the objective of evaluating the effects of sonication treatment on important quality parameters of extract of Bursa of Fabricius. Sonication of extract was done (frequency 20 kHz and various amplitude levels) at 0 °C for 10 min, 30 min, 50 min, respectively. As results, the yield of bursa peptides significantly increased (p<0.05). Then we found sonicated bursa extract promoted the content of bursin and the CFU pre-B formation, exerted immunomodulatory function on antigen-specific immune responses in C57/BL6 mice immunized with inactivated Japanese encephalitis b virus (JEV) vaccine, including enhancing JEV-specific antibody and cytokine production, T-cell immunophenotyping and lymphocyte proliferation. Findings of the present study suggested the sonication treatment of Bursa of Fabricius could improve the yield as well as the quality of bursa peptides, indicating that sonication is effective in processing of bursa extract and could be a potential process for future immuno-pharmacological use.